Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gallbladder Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 11 Prostatic Neoplasms 8 Carcinoma, Hepatocellular 7 Liver Neoplasms 5 Neoplasm Metastasis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Neoplasms 2 Melanoma 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Unresectable Pancreatic Cancer 1 Triple Negative Breast Neoplasms 1 Squamous Intraepithelial Lesions 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1 Liver Diseases 1 HIV Seropositivity 1

Interventions

Gemcitabine 52 Cisplatin 35 Capecitabine 27 Oxaliplatin 25 Fluorouracil 19 Leucovorin 17 pembrolizumab 11 Irinotecan 11 durvalumab 8 Erlotinib Hydrochloride 8 130-nm albumin-bound paclitaxel 8 Bevacizumab 7 Trastuzumab 6 Radiotherapy 5 Carboplatin 5 Albumin-Bound Paclitaxel 5 Taxes 4 Sorafenib 4 Platinum 4 Docetaxel 4 1,2-diaminocyclohexaneplatinum II citrate 4 trifluridine tipiracil drug combination 3 Magnetic Resonance Spectroscopy 3 Chemotherapy, Adjuvant 3 AZD 6244 3 zanidatamab 2 tremelimumab 2 toripalimab 2 regorafenib 2 lenvatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430662 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡